Literature DB >> 29725538

Appendiceal carcinoma associated with microsatellite instability.

Angélica Morales-Miranda1, Ismael Domínguez Rosado2, Carlos Chan Núñez2, Fredy Chable Montero3.   

Abstract

Approximately 15% of colorectal cancer (CRC) cases exhibit microsatellite instability (MSI), which appears to be associated with unique biological behavior. The present study presents a case of appendiceal carcinoma associated with MSI that responded well to adjuvant chemotherapy. Clinical, pathological and immunohistochemical (IHC) characteristics have been described. The 60-year-old male patient had suffered from recurrent lower abdominal pain associated with abdominal distention for 6 months; then, following an acute attack, he was subjected to laparoscopic appendectomy. The histopathological examination revealed moderately differentiated appendiceal adenocarcinoma with mucinous areas, without lymphovascular or perineural invasion. The IHC examination was positive for keratin-20 and caudal type homeobox 2, and negative for MutL Homolog 1, MutS Homolog (MSH) 2 and MSH-6. A postoperative colonoscopy revealed diverticulosis, without the presence of polyps or tumors. However, an abdominal axial computerized tomography scan revealed thickening of the distal portion of the appendix, increased density of the greater omentum, and metastases to the liver capsule, spleen and peritoneum. The treatment of choice was right hemicolectomy with peritoneal debulking, followed by 10 cycles of chemotherapy with 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX regimen). After 5 years of follow-up, the patient remains in good condition, without clinical or radiological signs of recurrence. The good response to chemotherapy corresponds with the observations made in other colon cancers with MSI. Therefore, testing for MSI in appendiceal carcinomas may provide useful information on prognosis and predict response to chemotherapy.

Entities:  

Keywords:  appendiceal adenocarcinoma; microsatellite instability; peritoneal metastases; prognosis

Year:  2018        PMID: 29725538      PMCID: PMC5920207          DOI: 10.3892/mco.2018.1596

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  32 in total

1.  Importance of histologic subtype in the staging of appendiceal tumors.

Authors:  Kiran K Turaga; Sam G Pappas; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

2.  Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?

Authors:  Tushar Samdani; Molly Schultheis; Zsofia Stadler; Jinru Shia; Tiffany Fancher; Justine Misholy; Martin R Weiser; Garrett M Nash
Journal:  Dis Colon Rectum       Date:  2015-03       Impact factor: 4.585

Review 3.  Surgery for colorectal peritoneal carcinomatosis.

Authors:  Terence C Chua; Joerg O W Pelz; David L Morris
Journal:  Scand J Gastroenterol       Date:  2012-01-23       Impact factor: 2.423

Review 4.  Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.

Authors:  Zsofia K Stadler
Journal:  Hematol Oncol Clin North Am       Date:  2015-02       Impact factor: 3.722

5.  Mucinous adenocarcinoma of the appendix.

Authors:  Iraj Feizi; Nasrollah Maleki; Zahra Tavosi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

6.  Malignant neoplasms of the appendix.

Authors:  Mark E O'Donnell; Stephen A Badger; Garth C Beattie; Jim Carson; W Ian H Garstin
Journal:  Int J Colorectal Dis       Date:  2007-04-20       Impact factor: 2.571

7.  The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.

Authors:  Elliot A Asare; Carolyn C Compton; Nader N Hanna; Lauren A Kosinski; Mary Kay Washington; Sanjay Kakar; Martin R Weiser; Michael J Overman
Journal:  Cancer       Date:  2015-10-27       Impact factor: 6.860

8.  High-level microsatellite instability in appendiceal carcinomas.

Authors:  Melissa W Taggart; John Galbincea; Paul F Mansfield; Keith F Fournier; Richard E Royal; Michael J Overman; Asif Rashid; Susan C Abraham
Journal:  Am J Surg Pathol       Date:  2013-08       Impact factor: 6.394

9.  Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.

Authors:  Christian N Arnold; Ajay Goel; C Richard Boland
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

10.  Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients.

Authors:  S C C Wong; S S M Ng; M T Cheung; L Y Luk; C M L Chan; A H K Cheung; V H M Lee; P B S Lai; B B Y Ma; E P Hui; M Y Y Lam; T C C Au; A T C Chan
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.